Mednet Logo

Can a second course of SRS be used to treat a brain met that initially responded to SRS and then progressed?

If progression is proven by imaging modality (MRI spectroscopy, perfusion and PET/CT), is there evidence for retreatment with a second course of SRS? If so, should a lower dose be used than would be typically used for the same size lesion?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

One should use caution in interpreting imaging as a definitive sign of progression, as sometimes radiation necrosis can mimic those findings. if asymptomatic, the patient can be considered for close observation with imaging and if symptomatic, one should consider a surgical option also.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Washington University School of Medicine
Answered on

If there is compelling evidence for recurrence, there are a few small case series that demonstrate feasibility of repeat SRS. We recently presented our own series at ASTRO (http://www.redjournal.org/article/S0360-3016(14)01740-4/fulltext) demonstrating a 1y LRFS of 62.4% with 17% risk (4 pts) of gra...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Yale School of Medicine
Answered on

I agree with caution in interpreting the results of PET and MRI spectroscopy. The specificity of PET, MRI, and MR spectroscopy vary from 50-80%. We have had a number of cases in which PET and MR spec were consistent with progressive disease and surgical pathology on the whole lesion showed radionecr...

Join for free or sign in to see the full answer